2012
DOI: 10.1007/s11136-012-0261-0
|View full text |Cite
|
Sign up to set email alerts
|

Validation of the Arabic version of the EORTC quality of life questionnaire among cancer patients in Lebanon

Abstract: The translated Lebanese Arabic version of the EORTC QLQ-C30 is a reliable and valid instrument that can be used to assess the quality of life of Lebanese cancer patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
63
0
8

Year Published

2014
2014
2021
2021

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 48 publications
(77 citation statements)
references
References 24 publications
6
63
0
8
Order By: Relevance
“…To an extent, similar findings regarding item 5 were reported in published studies. 23 , 24 The results of discriminant validity were satisfactory, with the exception of item 5 (self-care), which showed a higher correlation with role and social functioning, GH/QoL subscale, nausea/vomiting, and pain than with its corresponding physical functioning subscale. Total item-discriminant validity success was 89.1%.…”
Section: Discussionmentioning
confidence: 90%
“…To an extent, similar findings regarding item 5 were reported in published studies. 23 , 24 The results of discriminant validity were satisfactory, with the exception of item 5 (self-care), which showed a higher correlation with role and social functioning, GH/QoL subscale, nausea/vomiting, and pain than with its corresponding physical functioning subscale. Total item-discriminant validity success was 89.1%.…”
Section: Discussionmentioning
confidence: 90%
“…Similar results were found in other studies reporting for Cronbach's alpha for six subscales. [ 19 20 21 ]…”
Section: Discussionmentioning
confidence: 99%
“…The EORTC has cancer-specific multi-scale QoL measures that are available in various languages for QoL assessment in different cultural settings [ 17 18 19 20 21 ]. The present study used the Korean versions of the EORTC QLQ-C30 and its gastric cancer-specific module (EORTC QLQ-STO22) [ 22 ].…”
Section: Methodsmentioning
confidence: 99%